NYSE: EMNEastman Chemical Co Stock
$81.56+1.28 (+1.59%)
Updated Jul 10, 2025
EMN Price
$81.56
Fair Value Price
N/A
Market Cap
$9.42B
52 Week Low
$70.90
52 Week High
$114.50
P/E
10.28x
P/B
1.6x
P/S
1.08x
PEG
2.36x
Dividend Yield
4.05%
Revenue
$9.36B
Earnings
$922.00M
Gross Margin
24.8%
Operating Margin
14.02%
Profit Margin
9.8%
Debt to Equity
1.54
Operating Cash Flow
$1B
Beta
1.07
Next Earnings
Jul 31, 2025
Ex-Dividend
N/A
Next Dividend
N/A
EMN Overview
Eastman Chemical Company manufactures chemicals, fibers, and plastics. It provides coatings, adhesives, and specialty plastics products, as well as cellulose acetate fibers. It also produces copolyesters for packaging. Eastman was founded in 1920 and is based in Kingsport, TN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EMN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important EMN news, forecast changes, insider trades & much more!
EMN News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EMN scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EMN ($81.56) is trading above its intrinsic value of $56.20, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EMN is good value based on its earnings relative to its share price (10.28x), compared to the US market average (30.8x)
P/E vs Market Valuation
EMN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more EMN due diligence checks available for Premium users.
Valuation
EMN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
10.28x
Industry
7.01x
Market
30.8x
EMN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EMN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
EMN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.6x
Industry
3.44x
EMN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EMN price to earnings growth (PEG)
For valuing profitable companies with growth potential
EMN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
EMN's financial health
Profit margin
Revenue
$2.3B
Net Income
$182.0M
Profit Margin
7.9%
EMN's Earnings (EBIT) of $1.31B... subscribe to Premium to read more.
Interest Coverage Financials
EMN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$15.0B
Liabilities
$9.0B
Debt to equity
1.54
EMN's short-term assets ($3.90B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EMN's long-term liabilities ($6.76B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EMN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EMN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$167.0M
Investing
-$131.0M
Financing
-$124.0M
EMN's operating cash flow ($1.14B)... subscribe to Premium to read more.
Debt Coverage Financials
EMN vs Specialty Chemical Stocks
Eastman Chemical Co Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.